Adamis Pharmaceuticals has acquired US Compounding, a privately held company registered as a drug compounding outsourcing facility under Section 503B of the U.S. Food, Drug & Cosmetic Act (FD&C Act), that provides prescription medications to patients, physician clinics, hospitals and surgery centers throughout most of the U.S. US Compounding will become a wholly-owned subsidiary of Adamis. “USC will be a compelling addition for Adamis. We believe the combination of revenues of $20 mil...